472 related articles for article (PubMed ID: 32741218)
1. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
[No Abstract] [Full Text] [Related]
3. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
Piccolo V; Neri I; Manunza F; Mazzatenta C; Bassi A
Int J Dermatol; 2020 Aug; 59(8):1026-1027. PubMed ID: 32496583
[No Abstract] [Full Text] [Related]
4. Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
Recalcati S; Fantini F
Int J Dermatol; 2020 Aug; 59(8):e268-e269. PubMed ID: 32572958
[No Abstract] [Full Text] [Related]
5. Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay.
Hébert V; Duval-Modeste AB; Joly P; Lemée V; Cellier L; Jouen F; Veber B; Drouot L; Boyer O
J Am Acad Dermatol; 2020 Nov; 83(5):1434-1436. PubMed ID: 32682889
[No Abstract] [Full Text] [Related]
6. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions.
Denina M; Pellegrino F; Morotti F; Coppo P; Bonsignori IM; Garazzino S; Ravanini P; Avolio M; Cavallo R; Bertolotti L; Felici E; Acucella G; Montin D; Rabbone I; Licciardi F
J Am Acad Dermatol; 2020 Dec; 83(6):1751-1753. PubMed ID: 32781180
[No Abstract] [Full Text] [Related]
7. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
[TBL] [Abstract][Full Text] [Related]
8. Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France.
de Masson A; Bouaziz JD; Sulimovic L; Cassius C; Jachiet M; Ionescu MA; Rybojad M; Bagot M; Duong TA;
J Am Acad Dermatol; 2020 Aug; 83(2):667-670. PubMed ID: 32380219
[No Abstract] [Full Text] [Related]
9. Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
Rizzoli L; Collini L; Magnano M; Termine S; Barcelli R; Infusino SD; Bauer P; Rech G; Girardelli CR; Balestri R
Br J Dermatol; 2020 Oct; 183(4):782-784. PubMed ID: 32613620
[No Abstract] [Full Text] [Related]
10. Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic.
Herman A; Peeters C; Verroken A; Tromme I; Tennstedt D; Marot L; Dachelet C; Gruson D; Hermans C; Baeck M
JAMA Dermatol; 2020 Sep; 156(9):998-1003. PubMed ID: 32584377
[TBL] [Abstract][Full Text] [Related]
11. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
[TBL] [Abstract][Full Text] [Related]
12. Chilblain-like lesions with prominent bullae in a patient with COVID-19.
Rubin A; Alamgir M; Rubin J; Rao BK
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33139373
[TBL] [Abstract][Full Text] [Related]
13. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
Kerber AA; Soma DB; Youssef MJ
Int J Dermatol; 2020 Aug; 59(8):1024-1025. PubMed ID: 32496578
[No Abstract] [Full Text] [Related]
14. Chilblains in children in the setting of COVID-19 pandemic.
Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
[TBL] [Abstract][Full Text] [Related]
15. No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
Caselli D; Chironna M; Loconsole D; Nigri L; Mazzotta F; Bonamonte D; Aricò M
Br J Dermatol; 2020 Oct; 183(4):784-785. PubMed ID: 32613638
[No Abstract] [Full Text] [Related]
16. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
[No Abstract] [Full Text] [Related]
17. What Are COVID Toes? A Case Study.
Beuscher TL; Andrews SE
J Wound Ostomy Continence Nurs; 2020; 47(6):619-621. PubMed ID: 33201148
[TBL] [Abstract][Full Text] [Related]
18. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
McAdam AJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
[No Abstract] [Full Text] [Related]
19. Cutaneous lesions in a patient with COVID-19: are they related?
Ahouach B; Harent S; Ullmer A; Martres P; Bégon E; Blum L; Tess O; Bachmeyer C
Br J Dermatol; 2020 Aug; 183(2):e31. PubMed ID: 32353170
[No Abstract] [Full Text] [Related]
20. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.
Ruggiero G; Arcangeli F; Lotti T
Dermatol Ther; 2020 Jul; 33(4):e13616. PubMed ID: 32424851
[No Abstract] [Full Text] [Related]
[Next] [New Search]
